Efficacy against enveloped viruses.
To date, in accordance with the guidelines of the DVV* and RKI**, a description of the virucidal activity against Enveloped viruses only exists in Germany. For efficacy testing, the standards require in-vitro tests.
Both European and national norms require in vitro tests for proving the efficacy (quantitative suspension tests; in the EN referred to as phase 2/step 1).
* German Association for the Control of Virus Diseases
** Robert Koch-Institute